Optimising Type 2 Diabetes Care: Insights from Real-World PBS Data

Login to stream the interview or access our private podcast.

If you don't have a login, subscribe for free now (HCPs only).

12-Minutes

Play preview - to listen to full interviews
or Subscribe

More than one million Australians live with type 2 diabetes, with cardiovascular disease and chronic kidney disease remaining major causes of morbidity and mortality.

In this interview, endocrinologist Dr Tamara Milder shares real-world PBS prescribing data, highlighting gaps in the uptake of SGLT2 inhibitors and GLP-1 receptor agonists, and discusses what the PBS changes mean for GPs.

Host

Dr Anita Sharma

GP, Platinum Medical Centre, Chermside, Brisbane.

Guest Experts

Dr Tamara Milder

Endocrinologist, St Vincent’s Clinic in Sydney.

Resources

FORXIGA® (dapagliflozin) References that support the interview

GP Edition 168.

Supported by: Commissioned and funded by AstraZeneca, 66 Talavera Road, Macquarie Park, NSW, 2113. Produced May 2026.

Rate this interview

We value your feedback so tell us what you think (1:Not useful, 2:Partly useful, 3:Useful, 4:Very useful, 5:Extremely useful)

1 2 3 4 5

* all mandatory fields

I would like to receive the complimentary mailer (CD included for some programs)

I have read the terms of use

Thanks for your subscription. An email with your password and the account activation link has been sent to you. You need to activate your account by clicking on the activation link. If you haven’t received an email, please contact us at: admin@drivetimeradio.com.au

Sorry, something wrong happened. Please have a try later.

Optimising Type 2 Diabetes Care: Insights from Real-World PBS Data

Optimising Type 2 Diabetes Care: Insights from Real-World PBS Data

Host

Dr Anita Sharma

Guest Experts

Dr Tamara Milder

Resources

Rate this interview

It’s easy, join here

Log in

You must login or join to access this content